Arbutus Biopharma (ABUS) Price to Earnings (2010 - 2026)
Arbutus Biopharma's (ABUS) Price to Earnings was 6.20 for Q2 2026, up 12.4% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Price to Earnings (2010 - 2026) Analysis & Trends
For FY2012, Price to Earnings at Arbutus Biopharma was 2.38.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Arbutus Biopharma | 758.95 Mn | 142.14 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.32 |
| Jun 30, 2026 | 6.20 |
| Mar 31, 2026 | 5.51 |
| Sep 30, 2013 | 3.71 |
| Jun 30, 2013 | 2.28 |
| Mar 31, 2013 | 2.20 |
| Dec 31, 2012 | 2.36 |
| Mar 31, 2010 | 2.40 |
API Access
Arbutus Biopharma Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();